Dabrafenib Alleviates the Effects of Lipopolysaccharides in Endothelial Cells
Drug Research · 12.10.2026
DOI: 10.1055/a-2965-5307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 12.10.2026. Verfasst von Saikat Fakir und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Louisiana Monroe, School of Basic Pharmaceutical and Toxicological Sciences, Louisiana, USA, Monroe. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
The vascular endothelium forms a monolayer which regulates the passage of solutes and gases—including oxygen—between blood and tissues. Endothelial barrier dysfunction has been associated with sepsis, acute lung injury and acute respiratory distress syndrome. Dabrafenib is a food and drug administration–approved v-raf murine sarcoma viral oncogene homolog B1 inhibitor associated with anti-inflammatory responses, which targets the never in mitosis A-related kinase 9 and cyclin-dependent kinase 16. The present study suggests that dabrafenib ameliorates lipopolysaccharide-induced vascular injury by suppressing MLC2, MAPK, and STAT activation; paracellular leak and ROS generation, suggesting its potential use in diseases related to barrier dysfunction.
Autor:innen und Institutionen
- College of Pharmacy, University of Louisiana Monroe, School of Basic Pharmaceutical and Toxicological Sciences, Louisiana, USA, Monroe.
ORCID-Profile: Nektarios Barabutis
Zitieren
APA
Fakir, S., Sarker, M. M. R., Sigdel, M., & Barabutis, N. (2026). Dabrafenib Alleviates the Effects of Lipopolysaccharides in Endothelial Cells. Drug Research. https://doi.org/10.1055/a-2965-5307
Vancouver
Fakir S, Sarker MMR, Sigdel M, Barabutis N. Dabrafenib Alleviates the Effects of Lipopolysaccharides in Endothelial Cells. Drug Research. 2026. doi:10.1055/a-2965-5307
BibTeX
@article{Fakir2026,
author = {Fakir, Saikat and Sarker, Md Matiur Rahman and Sigdel, Madan and Barabutis, Nektarios},
title = {Dabrafenib Alleviates the Effects of Lipopolysaccharides in Endothelial Cells},
journal = {Drug Research},
year = {2026},
doi = {10.1055/a-2965-5307}
}
EUVIMED